Woodline Partners LP Humacyte, Inc. Transaction History
Woodline Partners LP
- $14.3 Billion
- Q1 2025
A detailed history of Woodline Partners LP transactions in Humacyte, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 3,950,000 shares of HUMA stock, worth $7.39 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
3,950,000
Previous 2,848,802
38.65%
Holding current value
$7.39 Million
Previous $14.4 Million
53.05%
% of portfolio
0.05%
Previous 0.11%
Shares
3 transactions
Others Institutions Holding HUMA
# of Institutions
180Shares Held
59.7MCall Options Held
1.05MPut Options Held
877K-
Black Rock Inc. New York, NY7.14MShares$13.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.6MShares$12.3 Million0.0% of portfolio
-
State Street Corp Boston, MA4.27MShares$7.98 Million0.0% of portfolio
-
Heights Capital Management, Inc San Francisco, CA4.03MShares$7.53 Million3.22% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.31MShares$6.19 Million0.12% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $193M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...